{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:04:04Z","timestamp":1760015044951},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,4,18]],"date-time":"2015-04-18T00:00:00Z","timestamp":1429315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s10238-015-0348-3","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T08:58:47Z","timestamp":1429261127000},"page":"227-232","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["CD38, CD81 and BAFFR combined expression by transitional B cells distinguishes active from inactive systemic lupus erythematosus"],"prefix":"10.1007","volume":"16","author":[{"given":"Ana","family":"Henriques","sequence":"first","affiliation":[]},{"given":"Isabel","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"In\u00eas","sequence":"additional","affiliation":[]},{"given":"M. Margarida","family":"Souto-Carneiro","sequence":"additional","affiliation":[]},{"given":"M. Lu\u00edsa","family":"Pais","sequence":"additional","affiliation":[]},{"given":"H\u00e9lder","family":"Trindade","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Ant\u00f3nio Pereira","family":"da Silva","sequence":"additional","affiliation":[]},{"given":"Artur","family":"Paiva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,4,18]]},"reference":[{"key":"348_CR1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","volume":"56","author":"CC Mok","year":"2003","unstructured":"Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56:481\u201390.","journal-title":"J Clin Pathol"},{"key":"348_CR2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","volume":"358","author":"A Rahman","year":"2008","unstructured":"Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358:929\u201339.","journal-title":"N Engl J Med"},{"key":"348_CR3","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, Mc Clain MT, Rubertone MV, Hal Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349:1526\u2013e1533.","journal-title":"N Engl J Med"},{"key":"348_CR4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2567.2003.01756.x","volume":"110","author":"LD Wang","year":"2003","unstructured":"Wang LD, Clark MR. B-cell antigen-receptor signalling in lymphocyte development. Immunology. 2003;110:411\u201320.","journal-title":"Immunology"},{"key":"348_CR5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.192.10.1453","volume":"192","author":"M Batten","year":"2000","unstructured":"Batten M, Groom J, Cachero TG, et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med. 2000;192:1453\u201366.","journal-title":"J Exp Med"},{"key":"348_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2567.2012.03602.x","volume":"137","author":"F Vences-Catal\u00e1n","year":"2012","unstructured":"Vences-Catal\u00e1n F, Rajapaksa R, Levy S, Santos-Argumedo L. The CD19\/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes. Immunology. 2012;137:48\u201355.","journal-title":"Immunology"},{"key":"348_CR7","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.176.8.4590","volume":"176","author":"J Chen","year":"2006","unstructured":"Chen J, Chen Y, Reifsnyder PC, et al. Targeted disruption of CD38 accelerates autoimmune diabetes in NOD\/Lt mice by enhancing autoimmunity in an ADP-ribosyltransferase 2-dependent fashion. J Immunol. 2006;176:4590\u20139.","journal-title":"J Immunol"},{"key":"348_CR8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1313.004","volume":"1050","author":"JO Pers","year":"2005","unstructured":"Pers JO, Daridon C, Devauchelle V, et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci. 2005;1050:34\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"348_CR9","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/art.23678","volume":"58","author":"M Petri","year":"2008","unstructured":"Petri M, Stohl W, Chatham W, et al. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum. 2008;58:2453\u20139.","journal-title":"Arthritis Rheum"},{"key":"348_CR10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992;35:630\u201340.","journal-title":"Arthritis Rheum"},{"key":"348_CR11","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288\u201391.","journal-title":"J Rheumatol"},{"key":"348_CR12","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/sj.leu.2402584","volume":"16","author":"ML Sanchez","year":"2002","unstructured":"Sanchez ML, Almeida J, Vidriales B, et al. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia. 2002;16:1460\u20139.","journal-title":"Leukemia"},{"key":"348_CR13","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1038\/leu.2010.160","volume":"24","author":"ES Costa","year":"2010","unstructured":"Costa ES, Pedreira CE, Barrena S, et al. Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical cytometry. Leukemia. 2010;24:1927\u201333.","journal-title":"Leukemia"},{"key":"348_CR14","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.4049\/jimmunol.168.12.6279","volume":"168","author":"D Ulgiati","year":"2002","unstructured":"Ulgiati D, Pham C, Holers VM. Functional analysis of the human complement receptor 2 (CR2\/CD21) promoter: characterization of basal transcriptional mechanisms. J Immunol. 2002;168:6279\u201385.","journal-title":"J Immunol"},{"key":"348_CR15","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","volume":"26","author":"JJ Dongen van","year":"2012","unstructured":"van Dongen JJ, Lhermitte L, B\u00f6ttcher S, et al. EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708). EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia. 2012;26:1908\u201375.","journal-title":"Leukemia"},{"key":"348_CR16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.molimm.2012.07.002","volume":"53","author":"R Asokan","year":"2013","unstructured":"Asokan R, Banda NK, Szakonyi G, Chen XS, Holers VM. Human complement receptor 2 (CR2\/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE). Mol Immunol. 2013;53:99\u2013110.","journal-title":"Mol Immunol"},{"key":"348_CR17","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/rheumatology\/ker178","volume":"50","author":"MS Viegas","year":"2011","unstructured":"Viegas MS, Silva T, Monteiro MM, do Carmo A, Martins TC. Knocking out of CD38 accelerates development of a lupus-like disease in lpr mice. Rheumatology (Oxford). 2011;50:1569\u201377.","journal-title":"Rheumatology (Oxford)"},{"key":"348_CR18","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/ard.2006.065656","volume":"66","author":"J Sellam","year":"2007","unstructured":"Sellam J, Miceli-Richard C, Gottenberg JE, et al. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus. Ann Rheum Dis. 2007;66:790\u20137.","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-015-0348-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-015-0348-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-015-0348-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T07:37:41Z","timestamp":1559115461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-015-0348-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,18]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["348"],"URL":"https:\/\/doi.org\/10.1007\/s10238-015-0348-3","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,18]]}}}